Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MCL1 |
| Upstream (Parents) |
|---|
| (<<) ACTB → MCL1 |
| (<<) CYB5R3 → MCL1 |
| (<<) RAB5A → MCL1 |
| (<<) RHOA → MCL1 |
| (<<) SHC1 → MCL1 |
| (<<) TPP1 → MCL1 |
| (<<) UBE2N → MCL1 |
| Downstream (Children) |
|---|
| MCL1 → ATP2A2 (>>) |
| MCL1 → CASP9 (>>) |
| MCL1 → CFL2 (>>) |
| MCL1 → CREB1 (>>) |
| MCL1 → CRKL (>>) |
| MCL1 → DAZAP2 (>>) |
| MCL1 → DHX9 (>>) |
| MCL1 → EIF2AK2 (>>) |
| MCL1 → ENO1 (>>) |
| MCL1 → EZR (>>) |
| MCL1 → GAPDH (>>) |
| MCL1 → GNA13 (>>) |
| MCL1 → HLA-G (>>) |
| MCL1 → HMGCS1 (>>) |
| MCL1 → HSP90AB1 (>>) |
| MCL1 → HSPA8 (>>) |
| MCL1 → JUND (>>) |
| MCL1 → KCTD5 (>>) |
| MCL1 → KLF6 (>>) |
| MCL1 → MAP3K2 (>>) |
| MCL1 → MAPK14 (>>) |
| MCL1 → MAPKAP1 (>>) |
| MCL1 → MAT2A (>>) |
| MCL1 → MERTK (>>) |
| MCL1 → MLX (>>) |
| MCL1 → MTAP (>>) |
| MCL1 → NFATC3 (>>) |
| MCL1 → NFKB2 (>>) |
| MCL1 → NMNAT1 (>>) |
| MCL1 → PDIA3 (>>) |
| MCL1 → PFDN1 (>>) |
| MCL1 → PGK1 (>>) |
| MCL1 → PIK3R2 (>>) |
| MCL1 → PIM1 (>>) |
| MCL1 → PPIB (>>) |
| MCL1 → PPIF (>>) |
| MCL1 → PRPF4B (>>) |
| MCL1 → PTPN11 (>>) |
| MCL1 → RAB5C (>>) |
| MCL1 → RAC2 (>>) |
| MCL1 → RAD51L3 (>>) |
| MCL1 → RNF5 (>>) |
| MCL1 → RPS12 (>>) |
| MCL1 → RXRB (>>) |
| MCL1 → SLC25A25 (>>) |
| MCL1 → STAT1 (>>) |
| MCL1 → TAGLN2 (>>) |
| MCL1 → TRIB1 (>>) |
| MCL1 → TSPAN3 (>>) |
| MCL1 → UBE2D1 (>>) |
| MCL1 → YWHAE (>>) |
